Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

c-Kit immunoexpression delineates a putative endothelial progenitor cell population in developing human lungs.

Suzuki T, Suzuki S, Fujino N, Ota C, Yamada M, Suzuki T, Yamaya M, Kondo T, Kubo H.

Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L855-65. doi: 10.1152/ajplung.00211.2013. Epub 2014 Feb 28.

PMID:
24583878
[PubMed - indexed for MEDLINE]
2.

Multiple gastrointestinal stromal tumors with novel germline c-kit gene mutation, K642T, at exon 13.

Yamanoi K, Higuchi K, Kishimoto H, Nishida Y, Nakamura M, Sudoh M, Hirota S.

Hum Pathol. 2014 Apr;45(4):884-8. doi: 10.1016/j.humpath.2013.11.009. Epub 2013 Nov 27.

PMID:
24565205
[PubMed - indexed for MEDLINE]
3.

The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia.

Schmitt-Graeff AH, Erben P, Schwaab J, Vollmer-Kary B, Metzgeroth G, Sotlar K, Horny HP, Kreipe HH, Fisch P, Reiter A.

Blood. 2014 Jan 23;123(4):595-7. doi: 10.1182/blood-2013-10-530642. No abstract available.

PMID:
24458279
[PubMed - indexed for MEDLINE]
4.

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.

Kristensen T, Vestergaard H, Bindslev-Jensen C, Møller MB, Broesby-Olsen S; Mastocytosis Centre, Odense University Hospital (MastOUH).

Am J Hematol. 2014 May;89(5):493-8. doi: 10.1002/ajh.23672. Epub 2014 Feb 21.

PMID:
24443360
[PubMed - indexed for MEDLINE]
5.

Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.

Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK.

Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):711-6. doi: 10.1073/pnas.1310501111. Epub 2013 Dec 30.

PMID:
24379393
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.

Lee JH, Kim Y, Choi JW, Kim YS.

J Gastrointestin Liver Dis. 2013 Dec;22(4):413-8. Review.

PMID:
24369323
[PubMed - indexed for MEDLINE]
Free Article
7.

KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

Cavnar MJ, Zeng S, Kim TS, Sorenson EC, Ocuin LM, Balachandran VP, Seifert AM, Greer JB, Popow R, Crawley MH, Cohen NA, Green BL, Rossi F, Besmer P, Antonescu CR, DeMatteo RP.

J Exp Med. 2013 Dec 16;210(13):2873-86. doi: 10.1084/jem.20130875. Epub 2013 Dec 9.

PMID:
24323358
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.

Allegra M, Giacchero D, Segalen C, Dumaz N, Butori C, Hofman V, Hofman P, Lacour JP, Bertolotto C, Bahadoran P, Ballotti R.

J Invest Dermatol. 2014 May;134(5):1473-6. doi: 10.1038/jid.2013.525. Epub 2013 Dec 6. No abstract available.

PMID:
24317392
[PubMed - indexed for MEDLINE]
9.

Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?

Santini D, Vincenzi B, Venditti O, Dell'Aquila E, Frezza AM, Silletta M, Guida FM, Grasso RF, Silvestris N, Lanzetta G, Tonini G.

Future Oncol. 2013 Dec;9(12):1809-11. doi: 10.2217/fon.13.170.

PMID:
24295410
[PubMed - indexed for MEDLINE]
10.

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.

Erben P, Schwaab J, Metzgeroth G, Horny HP, Jawhar M, Sotlar K, Fabarius A, Teichmann M, Schneider S, Ernst T, Müller MC, Giehl M, Marx A, Hartmann K, Hochhaus A, Hofmann WK, Cross NC, Reiter A.

Ann Hematol. 2014 Jan;93(1):81-8. doi: 10.1007/s00277-013-1964-1. Epub 2013 Nov 27.

PMID:
24281161
[PubMed - indexed for MEDLINE]
11.

Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.

Manara E, Bisio V, Masetti R, Beqiri V, Rondelli R, Menna G, Micalizzi C, Santoro N, Locatelli F, Basso G, Pigazzi M.

Leukemia. 2014 May;28(5):1132-4. doi: 10.1038/leu.2013.339. Epub 2013 Nov 14. No abstract available.

PMID:
24226631
[PubMed - indexed for MEDLINE]
12.

Transitory dasatinib-resistant states in KIT(mut) t(8;21) acute myeloid leukemia cells correlate with altered KIT expression.

Herrmann MD, Lennerz JK, Bullinger L, Bartholomae S, Holzmann K, Westhoff MA, Corbacioglu S, Debatin KM.

Exp Hematol. 2014 Feb;42(2):90-100. doi: 10.1016/j.exphem.2013.10.006. Epub 2013 Nov 6.

PMID:
24211243
[PubMed - indexed for MEDLINE]
13.

c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response.

Micheva-Viteva SN, Shou Y, Nowak-Lovato KL, Rector KD, Hong-Geller E.

BMC Microbiol. 2013 Nov 9;13:249. doi: 10.1186/1471-2180-13-249.

PMID:
24206648
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

ZNF16 (HZF1) promotes erythropoiesis and megakaryocytopoiesis via regulation of the c-KIT gene.

Chen J, Li XB, Su R, Song L, Wang F, Zhang JW.

Biochem J. 2014 Feb 15;458(1):171-83. doi: 10.1042/BJ20130628.

PMID:
24180487
[PubMed - indexed for MEDLINE]
15.

c-kit expression profile and regulatory factors during spermatogonial stem cell differentiation.

Zhang L, Tang J, Haines CJ, Feng H, Lai L, Teng X, Han Y.

BMC Dev Biol. 2013 Oct 27;13:38. doi: 10.1186/1471-213X-13-38.

PMID:
24161026
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit.

Pradier A, Tabone-Eglinger S, Huber V, Bosshard C, Rigal E, Wehrle-Haller B, Roosnek E.

Eur J Immunol. 2014 Feb;44(2):511-20. doi: 10.1002/eji.201343868. Epub 2013 Nov 20.

PMID:
24150691
[PubMed - indexed for MEDLINE]
17.

Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.

Beadling C, Patterson J, Justusson E, Nelson D, Pantaleo MA, Hornick JL, Chacón M, Corless CL, Heinrich MC.

Cancer Med. 2013 Feb;2(1):21-31. doi: 10.1002/cam4.57. Epub 2013 Feb 3.

PMID:
24133624
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.

Zeron-Medina J, Wang X, Repapi E, Campbell MR, Su D, Castro-Giner F, Davies B, Peterse EF, Sacilotto N, Walker GJ, Terzian T, Tomlinson IP, Box NF, Meinshausen N, De Val S, Bell DA, Bond GL.

Cell. 2013 Oct 10;155(2):410-22. doi: 10.1016/j.cell.2013.09.017.

PMID:
24120139
[PubMed - indexed for MEDLINE]
19.

Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.

Mikami T, Nemoto Y, Numata Y, Hana K, Nakada N, Ichinoe M, Murakumo Y, Okayasu I.

Hum Pathol. 2013 Dec;44(12):2628-35. doi: 10.1016/j.humpath.2013.07.020. Epub 2013 Oct 10.

PMID:
24119563
[PubMed - indexed for MEDLINE]
20.

Pak and Rac GTPases promote oncogenic KIT-induced neoplasms.

Martin H, Mali RS, Ma P, Chatterjee A, Ramdas B, Sims E, Munugalavadla V, Ghosh J, Mattingly RR, Visconte V, Tiu RV, Vlaar CP, Dharmawardhane S, Kapur R.

J Clin Invest. 2013 Oct 1;123(10):4449-63. doi: 10.1172/JCI67509. Epub 2013 Sep 16.

PMID:
24091327
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk